Skip to main content
Premium Trial:

Request an Annual Quote

Fisher s Q3 Revenues Grow 13 Percent as Profit More Than Doubles

NEW YORK, Nov. 9 (GenomeWeb News) - Fisher Scientific today reported a 13-percent increase in revenues, and more than doubled its net income for the three months ended Sept. 30.

 

Fisher's revenues for the third quarter rose to $1.4 billion from $1.26 billion in the same period a year ago.

 

Net income also surged to $94 million, or $0.77 per basic share, from $36 milllion, or $0.36 per basic share in the year-ago period.

 

Fisher Scientific had approximately $189.2 million in cash and cash investments as of Sept. 30.

 

The company did not report R&D expenditures for the quarter.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.